Sunshine Law Now in Effect


On August 1 manufacturers of drugs, medical devices and biologics that participate in federal health care programs began tracking and reporting certain payments and items of value - including consulting fees, travel reimbursements, research grants and other gifts - given to doctors and teaching hospitals.

Full content is available to CPMA members only. If you are a member, please log in to see the full content.